Bank of Montreal
NRIX icon

Bank of Montreal’s Nurix Therapeutics NRIX Stock Holding History

Bank of Montreal’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27,400
Closed -$294K – 4196
2023
Q4 		$294K Buy
+27,400
New +$188K ﹤0.01% 2873
2022
Q3 		– Sell
-24,104
Closed -$289 – 4311
2022
Q2 		$289 Buy
+24,104
New +$273K ﹤0.01% 3030
2021
Q4 		– Sell
-164,255
Closed -$5.37M – 3748
2021
Q3 		$5.37M Buy
+164,255
New +$5.07M ﹤0.01% 1596
2021
Q2 		– Sell
-709
Closed -$23K – 4528
2021
Q1 		$23K Sell
709
-1,112
-61% -$42.1K ﹤0.01% 3997
2020
Q4 		$73K Buy
1,821
+1,307
+254% +$43.3K ﹤0.01% 3750
2020
Q3 		$13K Buy
+514
New +$13K ﹤0.01% 4027

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of Montreal's NRIX Position: Q1 2024 in Review

Bank of Montreal sold out of Nurix Therapeutics (NRIX) in Q1 2024, closing a stake of 27,400 shares — an estimated $294K sold.

Bank of Montreal first reported a position in NRIX in Q3 2020 and held it in 6 quarters. The position peaked at $5.37M in Q3 2021. 139 funds tracked by Wall St. Rank hold NRIX as of Q1 2024.

  • Bank of Montreal reported no remaining Nurix Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 27,400 Nurix Therapeutics shares in Q1 2024, an estimated $294K.
  • Bank of Montreal first reported a position in Nurix Therapeutics in Q3 2020 and held it in 6 quarters.
  • Bank of Montreal's Nurix Therapeutics position peaked at $5.37M in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.